Health Care & Life Sciences » Biotechnology | Vitro Diagnostics Inc.

Vitro Diagnostics Inc. | Cash Flow

Fiscal year is November-October. All values USD Thousands.
2012
2013
2014
2015
2017
Net Income before Extraordinaries
227.70
211.20
246.50
245.90
450.20
Depreciation, Depletion & Amortization
20.10
15.30
17.70
15.80
2.40
Other Funds
143.80
114.00
141.10
-
154.40
Funds from Operations
190.30
178.40
192.90
201.00
447.80
Changes in Working Capital
59.60
70.90
72.90
100.60
117.50
Net Operating Cash Flow
130.60
107.50
120.00
100.40
565.30
Capital Expenditures
6.00
9.80
2.70
11.80
125.90
Sale of Fixed Assets & Businesses
-
-
-
-
120.50
Net Investing Cash Flow
6.00
9.80
2.70
11.80
43.00
Issuance/Reduction of Debt, Net
4.90
0.20
17.90
114.70
372.10
Net Financing Cash Flow
138.90
114.20
123.20
114.70
607.80
Net Change in Cash
2.30
3.10
0.60
2.50
0.50
Free Cash Flow
132.80
113.40
121.20
103.30
691.30
Change in Capital Stock
-
-
-
-
53.00
Other Uses
-
-
-
-
37.50

About Vitro Diagnostics

View Profile
Address
4621 Technology Drive
Golden Colorado 80403
United States
Employees -
Website http://www.vitrobiopharma.com
Updated 07/08/2019
Vitro Diagnostics, Inc. develops and commercializes adult stem cell technology for applications in stem cell research, drug development and therapeutic products for treatment a vast variety of diseases and conditions. It also offer a series of tools to promote the development of stem cell research and clinical applications focusing on Mesenchymal Stem Cells. The company was founded by James R.